Research Institute

Trials for high risk prostate cancer evaluating de-intensification and intensification w/radiation

Parallel Phase III randomized trials for high risk prostate cancer evaluating de-intensification for lower genomic risk and intensification of concurrent therapy for higher genomic risk with radiation

Disease Types: Prostate

Available at: Roanoke

Parallel Phase III randomized trials for high risk prostate cancer evaluating de-intensification for lower genomic risk and intensification of concurrent therapy for higher genomic risk with radiation

For More Information:

https://clinicaltrials.gov/study/NCT04513717?term=Parallel%20Phase%20III%20randomized%20trials%20for%20high%20risk%20prostate%20cancer%20evaluating%20de-intensification%20for%20lower%20genomic%20risk%20and%20intensification%20of%20concurrent%20therapy%20for%20higher%20genomic%20risk%20with%20radiation&rank=1